According to the IARC TP53 database, leiomyosarcoma corresponds to 9.1% of the sarcomas in TP53 mutation carriers, showing once again the particular behavior of the p.Arg337His pathogenic variant [23]. The gene discussed is TP53; the disease is leiomyosarcoma.